绝经后女性血浆雌二醇与睾酮水平及缺血性卒中风险
该巢式病例对照研究基于NHS队列,匹配419例绝经后缺血性卒中女性与419例对照,采用液相色谱串联质谱测定血浆雌二醇和睾酮,电化学发光法测定SHBG。按激素治疗状态分层分析,未发现激素水平与缺血性卒中风险存在明确线性趋势,但部分关联按BMI分层存在交互作用。结论不支持性激素水平介导绝经后女性缺血性卒中风险。
要点
- 当前激素治疗使用者与从未/过去使用者的激素谱不同。
- 雌二醇(总量或游离)及雌二醇/睾酮比值与缺血性卒中风险无明确线性趋势。
- 部分性激素与缺血性卒中的关联按BMI分层存在交互作用(Pinteraction≤0.04)。
核心结论
- 研究结果不支持性激素水平在绝经后女性中介导缺血性卒中风险。
- 需要在其他更大规模研究中重复验证。
研究设计与样本
- 巢式病例对照研究,来自NHS(护士健康研究)绝经后女性。
- 419例确诊新发缺血性卒中女性按年龄、激素治疗使用等因素与419例对照匹配。
- 血浆雌二醇和睾酮用液相色谱串联质谱测定,SHBG用电化学发光免疫分析法测定。
- 采用条件logistic回归按激素治疗状态分层,并调整匹配因素和心血管危险因素。
主要发现
- 当前激素治疗使用者与从未/过去使用者的激素谱不同。
- 当前使用者中雌二醇(总量或游离)水平或雌二醇/睾酮比值与缺血性卒中风险无明确线性趋势(Ptrend>0.1)。
- 从未/过去使用者中上述关联亦无明确线性趋势(Ptrend>0.6)。
- 当前和从未/过去使用者中,部分性激素与缺血性卒中的关联按BMI分层存在交互作用(Pinteraction≤0.04)。
- BMI<25 kg/m2的当前使用者中,较高雌二醇/睾酮比值与缺血性卒中风险显著升高相关(Ptrend=0.01)。
临床怎么用
- 临床不应依据血浆雌二醇或睾酮水平评估绝经后女性缺血性卒中风险。
- BMI可能修饰性激素与缺血性卒中的关联,但需进一步研究确认。
局限性
- 需要在其他更大规模研究中重复验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Although exogenous hormone therapy (HT) use has been associated with increased risk of ischemic stroke in postmenopausal women, it remains unknown whether sex hormone levels contribute to ischemic stroke risk. We aimed to estimate associations between plasma sex hormone levels and ischemic stroke risk, by HT status, in a nested case-control study of postmenopausal women from the NHS (Nurses' Health Study). Methods- Women with confirmed incident ischemic stroke (n=419) were matched with controls (n=419) by age, HT use, and other factors. Plasma estradiol and testosterone levels were measured using liquid chromatography tandem mass spectrometry; SHBG (sex hormone-binding globulin) was assayed by electrochemiluminescence immunoassay. Associations of total and free estradiol and testosterone, the estradiol/testosterone ratio, and SHBG with ischemic stroke were estimated using conditional logistic regressions stratified by HT status with adjustment for matching and cardiovascular risk factors. Results- Current HT users had different hormone profiles from never/past users. No clear linear trends were observed between estradiol (total or free) levels or the estradiol/testosterone ratio and ischemic stroke risk among either current users (Ptrend>0.1) or never/past users (Ptrend>0.6). For both current and never/past users, the associations between some of the sex hormones and ischemic stroke differed by body mass index categories (Pinteraction≤0.04). For women with a body mass index <25 kg/m2, a higher estradiol/testosterone ratio was associated with significantly elevated ischemic stroke risk among current users (Ptrend=0.01), and higher levels of total and free estradiol were significantly associated with higher ischemic stroke risk among never/past users (Ptrend≤0.04). Testosterone and SHBG were not associated with ischemic stroke in either current or never/past users. Conclusions- Our findings do not support a role of sex hormone levels in mediating ischemic stroke risk among postmenopausal women. Replications in additional larger studies are required.
引用
- Hu J, Lin JH, Jiménez MC, et al. Plasma Estradiol and Testosterone Levels and Ischemic Stroke in Postmenopausal Women. Stroke. 2020. PMID: 32078496. doi:10.1161/STROKEAHA.119.028588
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。